Status | Study |
Completed |
Study Name: Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD Condition: Peyronie's Disease Date: 2015-03-09 Interventions: Biological: Placental Matrix-Derived Mesenchymal Stem Cells (PMD-MSCs) Other Name: Ovation |
Active, not recruiting |
Study Name: Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease Condition: Peyronie's Disease Date: 2014-11-20 Interventions: Drug: Subjects Previously Treated with AA4500 no treatment to be administered - observational only |
Completed |
Study Name: An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease Condition: Peyronie's Disease Date: 2014-10-07 Interventions: Biological: AA4500 Other Names |
Active, not recruiting |
Study Name: Management of Peyronie's Disease With Adipose Tissue Stem Cell Condition: Erectile Dysfunction Peyronie' Disease Date: 2014-01-06 Interventions: Drug: Adipose tissue stem cell injection Stem cell will be harvested through adipose tissue by liposucti |
Completed |
Study Name: Peyronie's Disease Treatment Protocol Condition: Peyronie's Disease Date: 2013-07-09 Interventions: Drug: H-100 H-100 is a new com |
Completed |
Study Name: A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease Condition: Peyronie's Disease Date: 2012-09-12 Interventions: Biological: AA4500 2 injections separated by approximately 24 hours to 72 hours, repeated after 42 days |
Active, not recruiting |
Study Name: Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease Condition: Peyronie's Disease Date: 2012-04-12 Interventions: Drug: Vitamin D2 oral softgel |
Completed |
Study Name: Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease Condition: Peyronie's Disease Date: 2011-09-06 Interventions: Biological: AA4500 Two injections of AA4500 0.58 mg 24 hours apart |
Completed |
Study Name: A Study of AA4500 in Men With Peyronie's Disease Condition: Peyronie's Disease Date: 2010-11-17 Interventions: Biological: AA4500 2 injections separated by at least 24 hours but not more than 72 hours, repeated afte |
Completed |
Study Name: Study of AA4500 in the Treatment of Peyronie's Disease Condition: Peyronie's Disease Date: 2010-10-08 Interventions: Biological: AA4500 2 injection |